| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.5 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in Philips iSite, IntelliSpace PACS, iSite PACS and IntelliSpace PACS and classified as critical. Impacted is an unknown function. Performing a manipulation results in credentials management. This vulnerability is identified as CVE-2018-17906. The attack can only be performed from the local network. There is not any exploit available.
Details
A vulnerability, which was classified as critical, was found in Philips iSite, IntelliSpace PACS, iSite PACS and IntelliSpace PACS (Medical Device Software) (the affected version unknown). This affects an unknown part. The manipulation with an unknown input leads to a credentials management vulnerability. CWE is classifying the issue as CWE-255. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
Philips iSite and IntelliSpace PACS, iSite PACS, all versions, and IntelliSpace PACS, all versions. Default credentials and no authentication within third party software may allow an attacker to compromise a component of the system.
The bug was discovered 11/08/2018. The weakness was released 11/19/2018 (Website). It is possible to read the advisory at securityfocus.com. This vulnerability is uniquely identified as CVE-2018-17906 since 10/02/2018. The exploitability is told to be easy. The attack needs to be done within the local network. No form of authentication is needed for exploitation. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1552 according to MITRE ATT&CK.
The vulnerability was handled as a non-public zero-day exploit for at least 11 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 105875†). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.philips.ch/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.6VulDB Meta Temp Score: 7.6
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 8.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Credentials managementCWE: CWE-255
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
10/02/2018 🔍11/08/2018 🔍
11/08/2018 🔍
11/19/2018 🔍
11/19/2018 🔍
11/20/2018 🔍
04/14/2020 🔍
Sources
Vendor: philips.chAdvisory: securityfocus.com⛔
Status: Not defined
CVE: CVE-2018-17906 (🔍)
GCVE (CVE): GCVE-0-2018-17906
GCVE (VulDB): GCVE-100-127011
SecurityFocus: 105875 - Philips iSite and IntelliSpace PACS CVE-2018-17906 Local Security Weakness
Entry
Created: 11/20/2018 22:31Updated: 04/14/2020 09:24
Changes: 11/20/2018 22:31 (57), 04/14/2020 09:24 (3)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.